Next Article in Journal
Acute Promyelocytic Leukemia in a Woman with Thalassemia Intermedia: Case Report and Review of Literature on Hematological Malignancies in β-Thalassemia Patients
Previous Article in Journal
Case Report: α-Spectrin Mutation Associated with αLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause

by
Olga Lesniewska-Skowerska
*,
Joanna Symela-Kaspera
,
Lucyna Klimczak-Gołąb
,
Wojciech Smolka
and
Jaroslaw Markowski
Department of Laryngology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2022, 14(4), 305-309; https://doi.org/10.3390/hematolrep14040044
Submission received: 31 May 2022 / Revised: 18 September 2022 / Accepted: 8 October 2022 / Published: 10 October 2022

Abstract

Sinus tumors are arduous to diagnose due to often prolonging asymptomatic course until the infiltration of the adjacent structures occurs. Therefore, patients are diagnosed with advanced-stage disease, which negatively affects the treatment outcomes. A 60-year-old male was referred to our ward from an outpatient clinic. The patient presented with double vision, right-side lacrimation, and exophthalmos. He also reported significant weight loss: 15 kg in 2 months. Physical examination revealed achiness and edema of the right temporal area, and subconjunctival hemorrhage of the right eye, and surprisingly no anosmia, no nasal obstruction, and no head/neck lymphadenopathy were present. The histopathology examination identified diffuse large B-cell lymphoma (CD20+ CD3- p63- bcl-2+ CD23-/+ bcl-6+ CD 10- MUM1+ Tdt- CD38- cyclin D1- CD30- c-myc+). The patient was qualified for R-CHOP immunochemotherapy (rituximab, cyclophosphamide, and hydroxydaunorubicin hydrochloride), which was well tolerated. After 3 months of treatment, all of the symptoms reversed and a whole-body PET scan showed no abnormal metabolic activity.
Keywords: lympoma; sinus; maxillary; tumor lympoma; sinus; maxillary; tumor

Share and Cite

MDPI and ACS Style

Lesniewska-Skowerska, O.; Symela-Kaspera, J.; Klimczak-Gołąb, L.; Smolka, W.; Markowski, J. Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause. Hematol. Rep. 2022, 14, 305-309. https://doi.org/10.3390/hematolrep14040044

AMA Style

Lesniewska-Skowerska O, Symela-Kaspera J, Klimczak-Gołąb L, Smolka W, Markowski J. Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause. Hematology Reports. 2022; 14(4):305-309. https://doi.org/10.3390/hematolrep14040044

Chicago/Turabian Style

Lesniewska-Skowerska, Olga, Joanna Symela-Kaspera, Lucyna Klimczak-Gołąb, Wojciech Smolka, and Jaroslaw Markowski. 2022. "Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause" Hematology Reports 14, no. 4: 305-309. https://doi.org/10.3390/hematolrep14040044

APA Style

Lesniewska-Skowerska, O., Symela-Kaspera, J., Klimczak-Gołąb, L., Smolka, W., & Markowski, J. (2022). Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause. Hematology Reports, 14(4), 305-309. https://doi.org/10.3390/hematolrep14040044

Article Metrics

Back to TopTop